Journal
VACCINE
Volume 40, Issue 35, Pages 5189-5196Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2022.07.023
Keywords
SARS-CoV-2; Heterologous vaccination; Humoral immune response; Binding kinetics; Fc-mediated functions
Categories
Funding
- Fondo para la Convergencia Estruc-tural del Mercosur [COF 03/11]
- Fondo para la Convergencia Estructural del Mercosur [COF 03/11]
- Agencia Nacional deInvestigacion e Innovacion
- Comision Academica de Posgrado(CAP), Universidad de la Republica
Ask authors/readers for more resources
Heterologous prime-boost vaccination with CoronaVac and BNT162b2 led to a significant increase in serum anti-RBD specific antibody levels followed by a decrease. However, these levels remained higher than those in individuals vaccinated only with CoronaVac. Serum IgG levels were correlated with antibody binding, blocking RBD-ACE2 interaction, and Fc-effector mechanisms. This study provides insights into the humoral immune response to heterologous vaccination and the scheduling of future vaccine boosters.
Background: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has pro-ven to be a successful strategy for prevent severe infections. CoronaVac and BNT162b2 are the most used vaccines worldwide, but their use in heterologous vaccination schedules is still subjected to evaluation.Methods: Fifty healthy individuals who received heterologous prime-boost vaccination with CoronaVac and BNT162b2 were enrolled in a post-vaccination serological follow-up longitudinal prospective study. We evaluated specific serum anti-receptor binding domain (RBD) IgG antibody levels, and their capacity to block RBD-ACE2 interaction with a surrogate neutralization assay. In 20 participants, we assessed anti-body binding kinetics by surface plasmon resonance, and Fc-mediated functions by ADCC and ADCP reporter assays.Results: Our baseline seronegative cohort, displayed seroconversion after two doses of CoronaVac and an important decrease in serum anti-RBD IgG antibodies levels 80 days post-second dose. These levels increased significantly early after the third dose with BNT162b2, but 73 days after the booster we found a new fall. Immunoglobulin functionalities showed a similar behavior.Conclusions: The heterologous prime-boost vaccination with CoronaVac and BNT162b2 generated an impressive increase in serum anti-RBD specific antibody levels followed by a drop. Nevertheless, these titers remained well above those found in individuals only vaccinated with CoronaVac in the same elapsed time. Serum IgG levels showed high correlation with antibody binding analysis, their capacity to block RBD-ACE2 interaction, and Fc-effectors mechanisms. Our work sheds light on the humoral immune response to heterologous vaccination with CoronaVac and BNT162b2, to define a post -vaccination correlate of protection against SARS-CoV-2 infection and to discuss the scheduling of future vaccine boosters in general population.(c) 2022 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available